Matinas BioPharma Announces Initiation of ENHANCE-IT Study of MAT9001 Against Vascepa®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to Matinas BioPharma Announces Initiation of ENHANCE-IT Study of MAT9001 Against Vascepa®
(NYSE: MTNB) Delayed: 0.18 --0 (-0%)
Previous Close $0.18    52 Week High $2.01 
Open $0.18    52 Week Low $0.41 
Day High $0.19    P/E N/A 
Day Low $0.17    EPS $0.00 
Volume 1,377,706